Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of King Pharmaceuticals Inc (KG) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of King Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1047699.
Total stock buying since 2010: $89,500.
Total stock sales since 2010: $59,990.
Total stock option exercises since 2010: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2010 | 10,000 | $89,500 | 7,000 | $59,990 | 414,760 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2010-12 | 0 | $0 | 0 | $0 | 414,760 | $0 |
| 2010-06 | 0 | $0 | 7,000 | $59,990 | 0 | $0 |
| 2010-05 | 10,000 | $89,500 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-12-31 | Carter Eric G (Chief Science Officer) | Option Ex | 37,940 | .00 | 0 |
| 2010-12-31 | Elrod James W (Chief Legal Officer, A. Sec.) | Option Ex | 40,940 | .00 | 0 |
| 2010-12-31 | Squicciarino Joseph (Chief Financial Officer) | Option Ex | 74,820 | .00 | 0 |
| 2010-12-31 | Bruce Eric J (President, Animal Health) | Option Ex | 39,000 | .00 | 0 |
| 2010-12-31 | Markison Brian A (President and CEO) | Option Ex | 201,260 | .00 | 0 |
| 2010-12-31 | Brouillette Frederick Jr (Corporate Compliance Officer) | Option Ex | 20,800 | .00 | 0 |
| 2010-06-01 | Moyer Charles (Director) | Sale | 7,000 | 8.57 | 59,990 |
| 2010-05-14 | Schaffer Derace L (Director) | Buy | 10,000 | 8.95 | 89,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of KG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of King Pharmaceuticals Inc (symbol KG, CIK number 1047699) see the Securities and Exchange Commission (SEC) website.